# OnCo record nct02997228 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02997228/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02997228", "NCT02997228" ;
  schema:name "Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study"@en ;
  schema:description "A phase 3 trial of atezolizumab, bevacizumab (glioblastoma use), fluorouracil (5-FU) and fOLFOX (5-FU, leucovorin, oxaliplatin) in colorectal cancer, run by National Cancer Institute (NCI), active but no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct02997228/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02997228> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/>, <https://onco.cc/cancers/colon-cancer/>, <https://onco.cc/cancers/msi-high-colorectal/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:drugs <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/bevacizumab-glioma/>, <https://onco.cc/drugs/fluorouracil/>, <https://onco.cc/drugs/folfox/> .